Senate Transition Puts Kennedy Atop Health: Rx Marketing In Spotlight?

The return of Sen. Kennedy (D-Mass.) to the chairmanship of the Senate Health Committee could open a pipeline for the grand jury investigations of pharmaceutical marketing to feed into the Washington political debate.

More from Archive

More from Pink Sheet